Transforming Innovative Research Into Commercial Reality

The Lachesis Fund is an early stage seed fund investing in the technologies arising from research undertaken at the Universities of Derby, De Montfort, Leicester, Lincoln, Loughborough, Northampton, Nottingham and Nottingham Trent.

The Fund Provides venture capital investment to transform innovative research into commercial reality.

Who Can Apply

Any member of staff from our partner Universities who has an idea that they
would like to commercialise.

find out who can apply

How To Apply

Please talk to your technology transfer office or our fund managers in the first instance.
We will ask you to complete an initial application form.

find out how to apply

Haemostatix Ltd

Gyrometrics Profile

Gyrometric Ltd

Promethean Particles Profile

Promethean Particles Ltd


Read more

31st October 2012 - Haemostatix Ltd, a biopharmaceutical company, announced today that it has received an additional £1.4 million Translation Award from the Wellcome Trust to continue development of its innovative haemostat technology. The funding…
Read more

Braveheart Investment Group plc (BRH), the AIM-listed investment management group specialising in venture capital investments and investment services to business angels, high net worth individuals, family offices and public sector organisations, is pleased to…
Read more

Our Partners

De Montfort University Loughborough University University of Leicester The University of Nottingham Nottingham Trent University University of Lincoln
University of Derby University of Northampton Strathtay Ventures Ltd East Midlands Development Agency